Clinical significance of BRAF mutations in metastatic melanoma

Forty to eighty percent of melanoma tumors have activating mutations in BRAF although the clinical importance of these mutations is not clear. We previously reported an analysis of BRAF mutations in metastatic melanoma samples from 68 patients. In this study, we correlated patient baseline character...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang, David Z, Panageas, Katherine S, Osman, Iman, Polsky, David, Busam, Klaus, Chapman, Paul B
Format: Artigo
Language:Inglês
Published: BioMed Central 2004
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC544849/
https://ncbi.nlm.nih.gov/pubmed/15613230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-2-46
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items